یکشنبه 15 شهریور 1405
[Archive]
پذیرفته شده و در حال انتشار
برگشت به فهرست مقالات |
برگشت به فهرست نسخه ها
چکیده: (183 مشاهده)
Erectile dysfunction in male patients receiving MMT is a complex condition influenced by both biological and psychological factors. Methadone's effect on hormonal balance and the nervous system can disrupt sexual function, while mental health issues related to addiction and recovery can exacerbate the issue. An effective management plan should include hormonal assessment, psychological support, pharmacological therapy, and patient education. Encouraging healthier lifestyle choices and addressing both the physical and emotional aspects of ED can significantly enhance sexual health and overall quality of life for individuals in treatment for substance abuse.
فهرست منابع
1. Mirzaei SA, Yazdi-Feyzabadi V, Mehrolhassani MH, Nakhaee N, Oroomiei N. Unveiling the roadblocks: exploring substance use disorder treatment policies in Iran through a qualitative lens. Addict Sci Clin Pract. 2024;19(1):80. [DOI:10.1186/s13722-024-00511-4] [PMID] [PMCID]
2. Rostami M, Jalilian A, Mahdavi SA, Jalilian M, Karamouzian M. Years of healthy life lost due to illegal drug use in Iran: a national registry-based study. Int J Ment Health Addict. 2026;24(3):2316-29 [DOI:10.1007/s11469-025-01508-z]
3. Aghakhani N, Lopez V, Cleary M. Experiences and perceived social support among Iranian men on methadone maintenance therapy: a qualitative study. Issues Ment Health Nurs. 2017;38(9):692-97. [DOI:10.1080/01612840.2017.1341586] [PMID]
4. Gerra G, Manfredini M, Somaini L, Maremmani I, Leonardi C, Donnini C. Sexual dysfunction in men receiving methadone maintenance treatment: clinical history and psychobiological correlates. Eur Addict Res. 2016;22(3):163-75. [DOI:10.1159/000441470] [PMID]
5. Trajanovska AS, Vujovic V, Ignjatova L, Janicevic-Ivanovska D, Cibisev A. Sexual dysfunction as a side effect of hyperprolactinemia in methadone maintenance therapy. Med Arch. 2013;67(1):48-50. [DOI:10.5455/medarh.2013.67.48-50] [PMID]
6. Changchien TC, Hsieh TJ, Yen YC. Erectile dysfunction among male patients receiving methadone maintenance treatment: focusing on anxiety-related symptoms. Sex Med. 2024;12(4):qfae052. [DOI:10.1093/sexmed/qfae052] [PMID] [PMCID]
7. Ramli FF, Shuid AN, Pakri Mohamed RM, Tg Abu Bakar Sidik TMI, Naina Mohamed I. Health-seeking behavior for erectile dysfunction in methadone maintenance treatment patients. Int J Environ Res Public Health. 2019;16(21):4249. [DOI:10.3390/ijerph16214249] [PMID] [PMCID]
8. Bruneau J, Ahamad K, Goyer MÈ, Poulin G, Selby P, Fischer B, et al. Management of opioid use disorders: a national clinical practice guideline. CMAJ. 2018;190(9):E247-E257. [DOI:10.1503/cmaj.170958] [PMID]
9. Motazedian S, Entezam S, Banihashem S, Zahed G, Kheradmand A. Erectile dysfunction in methadone maintenance therapy. Int J High Risk Behav Addict. 2020;9(3):e100781. [DOI:10.5812/ijhrba.100781]
10. Hammarlund R, Crapanzano KA, Luce L, Mulligan L, Ward KM. Review of the effects of self-stigma and perceived social stigma on the treatment-seeking decisions of individuals with drug- and alcohol-use disorders. Subst Abuse Rehabil. 2018;9:115-136. [DOI:10.2147/SAR.S183256] [PMID] [PMCID]
11. Medina II WA, Conermann T. Opioid-induced endocrinopathy. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2025. Updated November 15, 2022. Accessed August 31, 2026. https://www.ncbi.nlm.nih.gov/books/NBK559211/
12. Cai Z, Song X, Zhang J, Yang B, Li H. Practical approaches to treat ED in PDE5i nonresponders. Aging Dis. 2020;11(5):1202-1218. [DOI:10.14336/AD.2019.1028] [PMID] [PMCID]
13. Durrani M, Bansal K. Methadone. In: StatPearls. Treasure Island, FL: StatPearls Publishing; 2025. Updated January 11, 2024. Accessed August 31, 2026. https://www.ncbi.nlm.nih.gov/books/NBK562216/
| بازنشر اطلاعات | |
 |
این مقاله تحت شرایط Creative Commons Attribution-NonCommercial 4.0 International License قابل بازنشر است. |
